DVAX Archived Articles
Dynavax Technologies (NASDAQ:DVAX) – Diversifying Beyond Hepatitis B While Solidifying HEPLISAV-B Leadership
Published on March 15, 2025
Dynavax Technologies (DVAX): Pioneering Vaccines to Protect Against Infectious Diseases
Published on November 30, 2024
Dynavax Technologies Corporation (NASDAQ:DVAX): Leveraging CpG 1018 Adjuvant to Drive Sustainable Growth
Published on September 24, 2024